Manary named Helene B. Roberson Professor of Pediatrics
ManaryMark Manary has been named the Helene B. Roberson Professor of Pediatrics at the School of Medicine. “Mark Manary is an outstanding choice for the Helene B. Roberson Professor of Pediatrics,” said Chancellor Mark S. Wrighton. “Dr. Manary has developed innovative approaches to improving the lives of children in Africa. He is a credit to his field and most deserving of this generous honor supported by an endowment gift from Helene B. Roberson.”
Employees reach out to neighbors in Forest Park Southeast
Photo by Robert BostonSome families in the Forest Park Southeast neighborhood will have a brighter holiday thanks to the generosity of School of Medicine employees.
Longer Life Foundation marks 10th anniversary
In its 10 years, the Longer Life Foundation has funded more than 48 research grants, awarding some $2 million to support studies on various topics.
WUSTL program in national spotlight
Washington University is in the spotlight for its pivotal role in the Genomics Education Partnership, a collaborative effort to provide research experience in genomics to undergraduate classrooms across the country.
Brain cooling prevents cell death in mice exposed to anesthesia
New research suggests cooling the brain may prevent the death of nerve cells that has been observed in infant mice exposed to anesthesia.
Danforth Foundation donates $10 million for neurodegenerative research
The Danforth Foundation has granted the Hope Center for Neurological Disorders at the School of Medicine a $10 million endowed gift for research.
Other ailments can affect survival of head and neck cancer
Inaccurate statistics undermine physicians’ ability to give patients a true prognosis, which prevents patients from deciding how best to spend their future time.
Manary named Roberson Professor of Pediatrics
Mark J. Manary, M.D., has been named the Helene B. Roberson Professor of Pediatrics at the School of Medicine.
Lung cancer vaccine to be evaluated at Siteman Cancer Center
A vaccine designed to prevent the recurrence of lung cancer is now being tested in centers around the world including the Siteman Cancer Center at the School of Medicine and Barnes-Jewish Hospital. The vaccine stimulates the immune system to destroy cells that carry a tumor-specific antigen called MAGE-A3. This antigen is not present in normal tissue but is found in several cancer types, including 35 percent to 50 percent of cases of the most common type of lung cancer, non-small cell lung cancer.
Model unravels rules that govern how genes are switched on and off
Illustration by Michaela HuntFor years, scientists have struggled to decipher the genetic instruction book that details where and when the 20,000 genes in a human cell will be turned on or off. Different genes operate in each cell type at different times, and this careful orchestration is what ultimately distinguishes a brain cell from a liver or skin cell. Now, scientists at the School of Medicine report they have developed a model of gene expression in yeast that predicts with a high degree of accuracy whether a gene will be switched on or off.
View More Stories